| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.4B | $2.2B | $1.9B | $0.3B | $0.2B | $0.2B | $0.2B |
| Cost of Revenue | $0.7B | $0.7B | $0.6B | $0.5B | $0.3B | $0.2B | $0.2B | $0.2B |
| Gross Profit | $2.0B | $1.7B | $1.5B | $1.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| R&D Expense | $0.7B | $0.6B | $0.5B | $0.4B | $0.2B | $0.2B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.4B | $0.5B | $0.5B | $0.1B | $0.1B | $0.0B | $0.0B |
| Net Income | $0.7B | $0.5B | $0.5B | $0.4B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $4.41 | $3.27 | $3.14 | $2.79 | $0.44 | $0.49 | $0.24 | $0.16 |
| EPS (Diluted) | $4.32 | $3.22 | $3.00 | $2.63 | $0.42 | $0.45 | $0.22 | $0.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.3B | $5.9B | $4.8B | $3.8B | $2.3B | $1.7B | $1.2B | $0.9B |
| Current Assets | $6.3B | $5.0B | $4.0B | $3.1B | $1.5B | $1.4B | $1.0B | $0.7B |
| Cash & Equivalents | $1.1B | $0.7B | $0.9B | $1.1B | $0.5B | $0.6B | $0.3B | $0.2B |
| Total Liabilities | $1.5B | $1.3B | $1.1B | $0.9B | $0.6B | $0.4B | $0.3B | $0.3B |
| Current Liabilities | $1.4B | $1.2B | $1.0B | $0.8B | $0.6B | $0.4B | $0.3B | $0.2B |
| Stockholders' Equity | $5.8B | $4.6B | $3.7B | $2.9B | $1.7B | $1.2B | $0.9B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.9B | $0.8B | $0.8B | $0.4B | $0.3B | — | — |
| Investing Cash Flow | $-0.7B | $-1.1B | $-1.0B | $-0.3B | $-0.5B | $-0.1B | — | — |
| Capital Expenditures | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $-0.0B | $-0.0B | $-0.0B | $0.0B | $0.0B | — | — |